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MaBACKGROUND Systemic arterial load impacts the symptomatic status and outcome of patients with calciﬁc degen-
erative aortic stenosis (AS). However, assessing vascular properties is challenging because the arterial tree’s behavior
could be inﬂuenced by the valvular obstruction.
OBJECTIVES This study sought to characterize the interaction between valvular and vascular functions in patients with
AS by using transcatheter aortic valve replacement (TAVR) as a clinical model of isolated intervention.
METHODS Aortic pressure and ﬂow were measured simultaneously using high-ﬁdelity sensors in 23 patients (mean
79  7 years of age) before and after TAVR. Blood pressure and clinical response were registered at 6-month follow-up.
RESULTS Systolic and pulse arterial pressures, as well as indices of vascular function (vascular resistance, aortic input
impedance, compliance, and arterial elastance), were signiﬁcantly modiﬁed by TAVR, exhibiting stiffer vascular behavior
post-intervention (all, p < 0.05). Peak left ventricular pressure decreased after TAVR (186  36 mm Hg vs. 162  23
mm Hg, respectively; p ¼ 0.003) but remained at >140 mm Hg in 70% of patients. Wave intensity analysis showed
abnormally low forward and backward compression waves at baseline, increasing signiﬁcantly after TAVR. Stroke volume
decreased (21  19%; p < 0.001) and correlated with continuous and pulsatile indices of arterial load. In the 48 h
following TAVR, a hypertensive response was observed in 12 patients (52%), and after 6-month follow-up, 5 patients
required further intensiﬁcation of discharge antihypertensive therapy.
CONCLUSIONS Vascular function in calciﬁc degenerative AS is conditioned by the upstream valvular obstruction that
dampens forward and backward compression waves in the arterial tree. An increase in vascular load after TAVR limits the
procedure’s acute afterload relief. (J Am Coll Cardiol 2015;65:423–33) © 2015 by the American College of Cardiology
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TABLE 1 Baseline Clinical and Demographic Data (N ¼ 23)
Age, yrs 79  7
Female 11 (47)
Body surface area, m2 1.68  0.15
NYHA functional class III or IV 9 (39)
Logistic EuroSCORE 10  7
Coronary heart disease 10 (43)
Chronic kidney disease 7 (30)
Mitral regurgitation (grade > mild) 7 (30)
ABBR EV I A T I ON S
AND ACRONYMS
AS = aortic stenosis
BCW = backward compression
wave
C = compliance
Ea = systemic arterial elastance
FCW = forward compression
wave
SVI = stroke volume index
TAVR = transcatheter aortic
valve replacement
WIA = wave intensity analysis
Z = impedance
Zc = characteristic impedance
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424additive effects of valvular obstruction and
vascular load (4). Thus, vascular stiffness
may be a source of LV systolic and diastolic
dysfunctions in patients with moderate
degrees of valve obstruction (3). This mecha-
nism helps explain abnormally high mor-
bidity and mortality rates in patients with
AS for whom classical obstruction indices
fail to predict outcomes (2).Cardiovascular risk factors
Hypertension 17 (74)
Diabetes 11 (48)
Dyslipidemia 12 (52)
Smoking 4 (17)
Taking cardiovascular treatment
ACEIs/ARBs 17 (74)
Diuretics 17 (73)
SEE PAGE 434Characterizing intrinsic properties of the
arterial tree remains particularly challenging
in AS because of the difﬁculties of uncou-
pling valvular and vascular functions in vivo
(5). Acute and chronic interventions on eitherBeta-blockers 9 (39)
Aldosterone receptor antagonists 4 (17)
Calcium antagonists 2 (9)
Nitrates 1 (4)
Statins 14 (61)
Values are mean  SD or n (%).
ACEIs ¼ angiotensin-converting enzyme inhibitors; ARBs ¼ angiotensin receptor
blockers; EuroSCORE ¼ European System for Cardiac Operative Risk Evaluation;
NYHA ¼ New York Heart Association.compartment cause reciprocal changes in the other.
For instance, changes in vascular resistance caused
by vasodilators (6,7) and exercise (8) induce signiﬁ-
cant modiﬁcations in valve hemodynamics. Likewise,
valve interventions may acutely impact arterial
function (9).
Although attempts have been made to quantify
vascular load in AS noninvasively (2,4), a rigorous
quantiﬁcation of arterial hemodynamics entails
simultaneous measurements of central aortic pres-
sure and ﬂow (10). Use of this invasive approach in a
small number of subjects has suggested that steady
and pulsatile loads are increased in symptomatic
degenerative calciﬁc AS, particularly during exercise
(8). However, measurements of vascular load might
be conditioned by upstream valvular obstruction.
This study was designed to characterize the inter-
action between valvular and vascular function in
patients with calciﬁc degenerative AS. We hypothe-
sized that transcatheter aortic valve replacement
(TAVR) offers a useful clinical model of isolated
valvular intervention to unmask underlying valvular-
vascular interactions of AS. Therefore, we analyzed
the acute changes induced by TAVR to understand
how valve obstruction impacts vascular function,
using state-of-the-art methods, including frequency
domain and wave intensity analyses (WIA) of high-
ﬁdelity data.
METHODS
STUDY POPULATION. We studied 23 consecutive
patients with severe symptomatic calciﬁc degenera-
tive AS undergoing TAVR (Table 1). Patients were
either in sinus rhythm or permanent right ventricular
(RV) pacing (n ¼ 3). No patient had signiﬁcant
aortic regurgitation (AR), and 7 patients had an ejec-
tion fraction of #45%. Low-gradient AS (mean:<40 mm Hg) was present in 9 patients and concomi-
tant low-ﬂow (stroke volume [SV] index of <35 ml/m2)
in 3 patients. Sixteen patients (74%) had a pre-
procedural diagnosis of hypertension requiring phar-
macotherapy. Antihypertensive agents were withheld
12 h before the procedure. After TAVR, patients were
initially kept on their pre-procedural antihypertensive
therapy. The local Institutional Review Board
approved the study protocol and all subjects provided
written informed consent.
STUDY PROTOCOL AND FOLLOW-UP. Procedures
were performed using the femoral approach under
local anesthesia and conscious sedation with low
doses of midazolam (2 to 5 mg, intravenous) and
fentanyl (2 mg/kg, intravenous); additional boluses
(1 mg and 50 mg, respectively) were used if necessary
to maintain patient comfort during the procedure.
Special care was taken to ensure a constant level of
sedation during pre- and post-procedural measure-
ments. A pacing wire and a thermodilution Swan-
Ganz catheter were placed in the RV and in the main
pulmonary artery, respectively. The self-expanding
valve (Corevalve, Medtronic, Inc., Minneapolis, Min-
nesota) transfemoral implantation procedure (11) was
successful in all patients. Mild residual AR was pres-
ent in 10 patients (grade 1 in 9 patients and grade
2 in 1 patient). Aortic and LV pressures were simul-
taneously recorded before and after TAVR, using
J A C C V O L . 6 5 , N O . 5 , 2 0 1 5 Yotti et al.
F E B R U A R Y 1 0 , 2 0 1 5 : 4 2 3 – 3 3 Systemic Vascular Load in Aortic Stenosis
425ﬂuid-ﬁlled catheters. Aortic valve areas were calcu-
lated using the Gorlin formula.
High-ﬁdelity pressure and ﬂow velocity were
recorded simultaneously at the ascending aorta by
using a 0.014-inch-diameter wire (Combowire, Vol-
cano Corp., San Diego, California) under stable he-
modynamic conditions (<10% variation in mean
blood pressure [BP] during $10 min before and $30
min after TAVR). To minimize artifacts within the
region of pressure recovery, the wire was introduced
though a 6-F multipurpose guiding catheter placed in
the ascending aorta w5 cm above the aortic annulus
(Central Illustration). The Doppler and micro-
manometry sensors located at the wire’s tip were
advanced approximately 1 cm out of the guiding
catheter before data recording. After TAVR, the
pressure-velocity wire was reinserted, matching the
tip’s position ﬂuoroscopically stored in the baseline
study. The pressure signal was balanced against the
ﬂuid-ﬁlled guiding catheter. Signals were recorded
for at least 1 minute during sinus rhythm and then
during RV pacing at 20 beats/min above intrinsic
baseline heart rate in all patients before and after
TAVR. In patients with permanent RV pacing or those
who were developing new-onset complete atrioven-
tricular or left branch bundle block (n ¼ 9), we used
pacing signals before and after TAVR. High-ﬁdelity
pressure, ﬂow velocity, and electrocardiogram sig-
nals were digitally stored at 200 Hz.
Comprehensive Doppler electrocardiogram exami-
nations were performed immediately before and<24 h
after TAVR, using broadband 2.0- to 4.0-MHz ma-
trix and volumetric transducers on a Vivid-7 or a
Vivid-9 system (General Electric Healthcare, Little
Chalfont, United Kingdom). Cuff BP was monitored
hourly during the ﬁrst 48 h and then every 8 h until
discharge. Hypertensive response after TAVR was
deﬁned (12) in the presence of 1 of the following:
1) sustained (>48-h) systolic pressure >140 mm Hg
or diastolic pressure >90 mm Hg not present before;
2) need for a >2-fold increase in the dosage of
an antihypertensive drug to achieve BP control; or
3) incorporation of an additional antihypertensive
drug to the pre-procedural regimen. Patients under-
went clinical follow-up, blinded to the results of
vascular hemodynamics, every 3 months during the
6 months’ post-procedure.
INVASIVE DATA PROCESSING AND ANALYSIS.
Volumetric ﬂow rate (ml/s) was calculated from linear
ﬂow velocity measurements (cm/s) by means of a
calibration constant (cm2) obtained as K ¼ SV/TVI,
where TVI represents the time-velocity integral and
SV is the simultaneously obtained thermodilution SV.Beats were selected for analysis if peak ascending
aortic pressure exhibited variation of <10 mm Hg over
the interval examined and the ﬂow velocity wave-
form was stable and periodic (8). For each hemody-
namic run, 13 beats (range: 5 to 19 beats) underwent
digital low-pass (50-Hz) ﬁltering and ensemble aver-
aging (Figure 1) (8,13). The aortic input impedance
spectrum was derived using Fourier decomposition of
the pressure and velocity signals up to 10 Hz (10).
Respective pressure and ﬂow moduli at each har-
monic were used to derive the impedance (Z) moduli.
Characteristic impedance (Zc) was calculated as the
average of Z moduli above 4 Hz, excluding outlier
values of >3 times the median. Because this method
is highly sensitive to signal noise, we additionally
calculated Zc from wave speed, the latter measured in
the time domain from the early P–Q linear relation-
ship, as used for measuring wave velocity (Online
Appendix). Correlation and agreement for both
methods for measuring Zc were r ¼ 0.67 and ric ¼ 0.59,
respectively (pooled before and after TAVR data). The
augmentation index was computed as the difference
between the maximum and minimum values of Z
components >3 Hz. We calculated the distance to the
reﬂecting site by the quarter-wavelength relationship
(14), as well as by WIA (r ¼ 0.51 and ric ¼ 0.40 between
methods [Online Appendix]). Arterial compliance (C)
was calculated using the pulse pressure method (15),
exponential decay, and diastolic area methods (10)
(r > 0.92 and ric $ 0.90, among all methods). We
calculated effective arterial elastance as: 1) the ratio
between end systolic pressure (obtained from the
ﬂuid-ﬁlled LV pressure catheter) and SV (Ea); and
2) the ratio between systemic vascular resistance
and the cardiac period (EaR; r ¼ 0.95 and ric ¼ 0.67
between methods) (16,17).
WIA is a well-established method used to assess
arterial hemodynamics (18); its foundations deﬁne
pressure and velocity waveforms as the summation
of successive inﬁnitesimal waves that propagate
through vessels (18). Arterial waves can originate
either from the LV (forward traveling) or from pe-
ripheral vasculature reﬂections (backward traveling).
Waves are further classiﬁed by their effect on pres-
sure as compression (increased pressure) or expan-
sion w (decreased pressure) waves. We used the
ensemble-averaged pressure and velocity signals to
derive the rates of change of aortic pressure (dP/dt)
and velocity (dU/dt) (Figure 1, Online Appendix). It
has been proposed that changes in aortic pressure
can be attributed not only to forward or backward
wave motion but also to changes in aortic volume
(19). Because we anticipated a potential effect of
TAVR on aortic pressure and volume, we also
CENTRAL ILLUSTRATION Systemic Vascular Load in Aortic Stenosis
Aortic impedance and wave intensity analysis are shown in a patient before (A) and after (B) transcatheter aortic valve replacement (TAVR). Aortic systolic and pulse
pressures increased after TAVR. Fourier decomposition of the simultaneous aortic pressure and velocity signals shows that SVR and the ﬁrst 3 harmonic frequencies of
the impedance spectrum (Z) increase after TAVR. Wave intensity analysis was used to separate total wave intensity into contributions from the forward (dIwþ) and
backward (dIw-) traveling waves. Compression waves (salmon) increase pressure, and expansion waves (green) decrease aortic pressure. The forward compression wave
(FCW) increases immediately after TAVR. BCW ¼ backward compression wave; BEW ¼ backward expansion wave; dIw ¼ wave intensity; FEW ¼ forward expansion wave;
LA ¼ left atrium; LV ¼ left ventricle; SVR ¼ systemic vascular resistance.
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FIGURE 1 High-Fidelity Pressure and Flow Velocity Signal Processing
Time
A
B C D
Time (ms) Time (ms) Aortic Flow Velocity (cm/s)
Ao
rt
ic
 P
re
ss
ur
e 
(m
m
 H
g)
Ao
rt
ic
 P
re
ss
ur
e 
(m
m
 H
g)
Ao
rt
ic
 P
re
ss
ur
e 
(m
m
 H
g)
Ao
rt
ic
 F
lo
w
 V
el
oc
ity
 (c
m
/s
)
Ao
rt
ic
 F
lo
w
 V
el
oc
ity
  (
cm
/s
)400
200
0
100
50
0
150 250
200
150
100
50
0
140
130
120
110
100
90
80
70
60
50
150
140
130
120
110
100
90
80
70
60
50
0 40 80 120 1600 500 1000 0 500 1000
Simultaneous high-ﬁdelity pressure and ﬂow velocity signals (A), ensemble signal average method (B and C), and wave speed estimation by
slope of the pressure-velocity relationship during early systole (D) are shown. See Online Appendix for details.
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427performed WIA taking reservoir pressure effect
into account (Online Figures 1 and 2) (19). All invasive
data were analyzed using custom-built algorithms
(Matlab; Mathworks, Natick, Massachusetts), and re-
sults for 3 to 5 hemodynamic runs were averaged for
each patient.
Noninvasive valvulo-arterial impedance (ZVA) was
calculated as: ½ZVA ¼ ðSBP þMGÞ=SVInoninv, whereSBP is the cuff systolic BP, MG is the Doppler-derived
mean transvalvular pressure gradient, and SVInoninv
is the noninvasive SV index (SVI) measured by
cross-sectional echocardiography and pulsed-wave
Doppler (2).
STATISTICAL ANALYSIS. Differences between pre-
and post-TAVR hemodynamic data were analyzed by
paired t tests. Responses between groups were
TABLE 2 Invasive Indices of Systemic Hemodynamics and
Valvular Function
Index Pre-TAVR Post-TAVR p Value
Global hemodynamics
Heart rate, beats/min 81  15 87  19 0.17
Stroke volume index, ml$m2 41  8 33  10 <0.001
Cardiac index, l$min$m2 3.3  0.8 2.8  1.1 <0.001
Systolic blood pressure, mm Hg 130  24 162  23 0.003
Diastolic blood pressure, mm Hg 59  11 67  11 0.08
Mean blood pressure, mm Hg 82  14 98  12 0.01
Pulse pressure, mm Hg 62  24 73  21 0.017
Peak systolic LV pressure, mm Hg 186  36 162  23 0.003
End-diastolic LV pressure, mm Hg 23  7 26  7 0.004
Valvular function
Mean transvalvular pressure
gradient, mm Hg
49  19 10  3 <0.0001
Aortic valve area, cm2 0.7  0.2 1.4  0.4 <0.0001
Values are mean  SD.
LV ¼ left ventricular; TAVR ¼ transcatheter aortic valve replacement.
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428compared using unpaired t tests. Correlation between
quantitative variables was analyzed using the linear
Pearson correlation coefﬁcient (r), and 95% conﬁ-
dence interval (CI) for the ﬁtting was plotted. The
intraclass correlation coefﬁcient (ric, absolute agree-
ment) was used to compare different methods. Out-
come analysis was performed by binary logistic
regression models, accounting for improvement in
New York Heart Association (NYHA) functional class
at follow-up. SVI pre- and post-TAVR and its changes
were entered separately in these models, adjusting
for age and pre-implantation functional class.
Because of the risk of overﬁtting in small samples,
overall performance of the model was calculated us-
ing 1,000 bootstrap resamples to estimate the C index
(20,21). Values of p< 0.05 were considered signiﬁcant.
RESULTS
INDICES OF AORTIC STENOSIS AND SYSTEMIC
HEMODYNAMICS. The large reduction in the trans-
valvular pressure gradient caused by TAVR was fol-
lowed by signiﬁcant increases in systolic, mean, and
pulse systemic arterial pressure values (Table 2).
Consequently, LV peak systolic pressure decreased by
only a mean of 10% (186  36 mm Hg vs. 162  23
mm Hg, respectively; p ¼ 0.003) and remained >140
mm Hg in 70% of patients, varying widely among
patients (Figure 2). After TAVR, SVI (41  8 ml/m2 vs.
33  10 ml/m2, respectively; p < 0.001) and cardiac
index (3.3  0.8 l/min/m2 vs. 2.8  1.1 l/min/m2,
respectively; p <0.001) decreased (Figure 2). Pa-
tients with and without residual aortic regurgitation
showed no signiﬁcant differences in post-procedural
LV end-diastolic pressure (31  9 mm Hg vs. 26  10
mm Hg, respectively; p ¼ 0.22).
SYSTEMIC VASCULAR LOAD. A signiﬁcant increase
in systemic vascular resistance, Ea, and the ﬁrst 3
harmonic frequencies of Z were observed after TAVR
(Table 3, Central Illustration). The augmentation index
and wave speed velocity increased as well, whereas C
decreased (Table 3). The amount of decrease in C after
TAVR was inversely related to baseline systolic BP
(r ¼ 0.72; p < 0.0001). SVI post-TAVR was strongly
related to indices of continuous and pulsatile arterial
load (Figure 3). Changes in SVI and arterial load
indices (C, Ea, systemic vascular resistance, and Zc)
were not signiﬁcantly different among patients who
did and did not require RV pacing after the procedure
(p $ 0.1 for all).
TAVR was followed by a signiﬁcant increase in for-
ward compression waves (FCW) and backward com-
pression waves (BCW) (Table 3, Central Illustration),
whereas expansion waves did not changesigniﬁcantly. Pulse pressure and Zc increased, as
measured by both the conventional and reservoir
approach methods (Online Table 1); the reﬂection
coefﬁcient increased following TAVR, whereas the
distance to reﬂection was only found to decrease by
using the reservoir method. Pulse pressure corre-
lated directly with compression waves (r ¼ 0.53 and
r ¼ 0.62 for peak FCWs and BCWs, respectively),
directly with the backward expansion wave (r ¼ 0.70),
and inversely with the forward expansion wave
(r ¼ 0.65; p < 0.0001 for all, pooled data and reser-
voir approach). The Zva did not change signiﬁcantly
with TAVR (4.1  1.2 mm Hg/ml/m2 vs. 3.9  1.4
mm Hg/ml/m2, respectively; p ¼ 0.59).
FOLLOW-UP. In the 48 h following TAVR, a hyper-
tensive response was observed in 12 patients (52%);
10 patients required intensiﬁcation of their anti-
hypertensive therapy and 1 initiation of treatment.
During 6 months of follow-up, 5 patients had
their discharge antihypertensive therapy intensiﬁed,
whereas no patient had reduced doses of these drugs.
NYHA functional class did not improve in 14 patients
(61%). Improvement in functional class after TAVR
was directly related to post-procedural SVI (odds-
ratio [OR]: 2.8 [95% CI: 1.1 to 7.3] per 5 ml; boot-
strapped C index: 0.67; p ¼ 0.03) and inversely to the
fall in SVI observed after TAVR (OR: 0.3 [95% CI: 0.1
to 0.9] per 5 ml; p ¼ 0.05), whereas it was not related
to pre-TAVR SVI (p ¼ 0.4).
DISCUSSION
The present study clariﬁes important aspects of
vascular adaptation to calciﬁc degenerative AS.
FIGURE 2 Hemodynamic Changes After TAVR
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429Using WIA, we demonstrated that valvular ob-
struction blunts the conversion of LV ejection blood
momentum into FCWs in the arterial system.
Dampened FCWs are reﬂected as abnormally low
BCWs at the aortic bifurcation sites, and both
effects result in low systolic and pulse arterial
pressures. This situation changes acutely after
TAVR, demonstrating that the characterization of
systemic vascular properties in AS is conditioned by
the upstream obstruction. The relief of the outﬂow
obstruction immediately raises FCWs and BCWs,
increasing arterial pressures and vascular imped-
ance and induces a stiffer vascular behavior. In our
study, the augmented vascular load correlated with
post-procedural SVI. Although this study was
limited to a small sample size, we found an inverse
relationship between the procedure’s mid-term
clinical beneﬁt and the change in SVI observed
post-TAVR.
VASCULAR TREE IN DEGENERATIVE CALCIFIC AS.
Noninvasive (4) and mathematical (5) methods havedescribed abnormally high steady and pulsatile
components of systemic arterial load in patients with
degenerative calciﬁc AS. However, few studies have
analyzed the status of intrinsic vascular properties in
AS invasively. Laskey et al. (8) compared 18 patients
with symptomatic degenerative calciﬁc AS to 11
younger control subjects and found higher vascular
resistance and impedance and reduced arterial
compliance in patients with AS. Differences between
groups became particularly evident during exercise
(8). However, our study’s results suggest that these
observations should be interpreted cautiously. By
analyzing the acute response to TAVR, we showed
that valve stenosis per se inﬂuences all metrics
characterizing the arterial tree. Noticeably, classical
values of vascular function obtained in our study pre-
TAVR did not differ from previously reported values
in age-matched hypertensive populations (22). How-
ever, WIA showed that compression and expansion
waves in AS are much lower than previously reported
normal values (23). We found that immediately after
TABLE 3 Steady and Pulsatile Arterial Hemodynamics at Baseline and After TAVR
Factor Pre-TAVR Post-TAVR p Value
Systemic vascular resistance index,
dyn∙s∙cm5∙m2
1841  562 2689  1271 <0.0001
Arterial compliance, pressure decay method,
ml∙mm Hg1
1.20  0.79 0.72  0.33 0.002
Arterial compliance, area method, ml∙mm Hg1 1.18  0.77 0.74  0.36 <0.001
Frequency domain analysis
Z at ﬁst harmonic frequency, dyn∙s∙cm5 519  219 763  280 <0.001
Z at second harmonic frequency, dyn∙s∙cm5 375  208 541  262 0.002
Z at third harmonic frequency, dyn∙s∙cm5 313  244 395  208 0.36
Characteristic impedance, dyn∙s∙cm5 258  139 326  193 0.06
Frequency of ﬁrst Z minimum, Hz 3.9  1.5 4.6  1.1 0.6
Arterial elastance, mm Hg∙ml1 1.2  0.46 1.75  0.70 <0.001
Arterial elastance, resistance method,
mm Hg∙ml1
1.09  0.40 1.63  0.65 <0.001
Augmentation index 392  232 750  739 0.025
Distance to reﬂection, m 0.11  0.72 0.12  0.09 0.06
Wave intensity analysis
Wave speed, m∙s1 3.57  2.05 4.62  2.01 0.034
Characteristic impedance, dyn∙s∙cm5 192  124 247  141 0.05
Forward wave
Iw total forward wave, W∙m2∙s1∙104 9.09  4.84 10.83  4.84 0.03
Iw FCW, W∙m2∙s1∙104 5.64  2.97 7.37  3.00 0.001
Peak dIw FCW, W∙m2∙s2∙106 1.01  0.54 1.80  0.66 <0.001
Iw FEW, W∙m2∙s1∙104 2.89  1.80 2.75  1.51 0.45
Peak dIw FEW, W∙m2∙s2∙106 0.51  0.31 0.46  0.30 0.68
Backward wave
Iw total backward wave, W∙m2∙s1∙104 3.71  2.68 5.23  2.28 0.04
Iw BCW, W∙m2∙s1∙104 2.34  1.72 3.39  2.17 0.04
Peak dIw BCW, W∙m2∙s2∙106 0.33  0.18 0.55  0.32 0.001
Iw BEW, W∙m2∙s1∙104 0.87  0.76 1.15  1.00 0.19
Peak dIw BEW, W∙m2∙s2∙106 0.21  0.18 0.23  0.21 0.75
Reﬂection
Reﬂection coefﬁcient 0.40  0.27 0.33  0.19 0.28
Distance to reﬂection, m 0.17  0.13 0.17  0.12 0.81
Values are mean  SD.
BCW ¼ backward compression wave; BEW ¼ backward expansion wave; dIw ¼ intensity; FCW ¼ forward
compression wave; FEW ¼ forward expansion wave; Iw ¼ cumulative wave intensity; Z ¼ impedance; other
abbreviations are as in Table 2.
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430TAVR, the transmission of blood momentum to the
arterial system improves, increasing FCWs. Stronger
FCWs are reﬂected as stronger BCWs traveling toward
the LV. Both effects raise mean, systolic, and pulse
arterial pressure levels.
Our results show that after TAVR, the vascular
tree exhibits a stiffer behavior. This paradoxical ef-
fect of rising continuous and pulsatile vascular load
after LV outﬂow relief was described previously (9).
In patients undergoing percutaneous aortic valvu-
loplasty, valvular-vascular interaction follows the
properties of complementarity (both compartments
contribute additively to afterload) and competitive-
ness (one compartment cannot be lowered without
raising the other one) (9,24). More recently, this
interaction was conﬁrmed in AS patients undergoingvasodilator pharmacological interventions (6). Our
study demonstrates the negative impact this
vascular response exerts on global hemodynamics of
patients undergoing TAVR. Although we did not
repeat invasive studies during follow-up, the rela-
tively large proportion of patients requiring antihy-
pertensive therapy scaling during follow-up suggests
that our acute observations are not acute phase
transients. Similar observations of persistent hyper-
tension have been reported after TAVR (12) and
surgical valve replacement (25).
Changes in the tone of large conduction arteries
and arterioles are probably responsible for the
observed changes in pulsatile vascular load after
TAVR. We know vasoconstriction in arteriolar vessels
reduces arterial compliance (14). The viscoelastic
properties of large conductance arteries also may be
responsible for this observation. Due to the nonline-
arity of viscoelastic strain of the large conductance
arteries, acute changes in the pressure-mediated
deformation post-TAVR may also induce stiffer
behavior of the vascular tree (26).
VASCULAR TREE AND OUTCOME IN AS. Indirect ev-
idence has emphasized the complementary impact of
arterial hemodynamics on the symptomatic status
and outcome of patients with AS, both before (2,4)
and after (27) valve intervention. The “double
loaded” hypothesis integrates these additive effects
of valvular and vascular loads. On this basis, the ZVA
index has been found to correlate with SV and
outcome (3,28). However, in our study, ZVA did not
capture the hemodynamic changes observed with
TAVR. The fact that ZVA did not improve acutely
probably relates to its sensitivity to both the valvular
and the vascular compartments, which are competi-
tively modiﬁed by therapy.
A well-known risk factor of cardiovascular
morbidity and mortality, especially in elderly patients
(29), hypertension has been associated with worse
outcomes in patients who undergo TAVR (30). How-
ever, a hypertensive response after TAVR has also
been associated with a better prognosis (12). In a
previous study, higher BP after TAVR was related to
higher SV and was attributed to an acute improve-
ment of LV function; patients with stable BP after
TAVR experienced, on average, a reduction in post-
procedural SV (12). Similarly, our study suggests
that a post-procedural reduction in SV is related to
absence of clinical improvement. However, we have
shown that the acute hypertensive response after
TAVR is caused by increased vascular load rather than
improved LV systolic function, so it should be
promptly identiﬁed and treated.
FIGURE 3 Correlation Between SVI and Indices of Arterial Load
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431LV IMPACT. Because no striking changes in chamber
systolic volume are expected during TAVR, the
observation of post-procedural increased arterial load
suggests that the hemodynamic beneﬁts of valvular
replacement on LV systolic wall stress may be lower
than expected, particularly in patients with relatively
low transvalvular pressure gradients. Although peak
LV pressure decreases after TAVR, it frequently
remained higher than normal. Increased post-
procedural vascular load may explain why patients
with paradoxically low-ﬂow low-gradient AS fail to
improve values of N-terminal prohormone B-type
natriuretic peptide by 1 year after TAVR (31) and have
a higher mortality than patients with normal ﬂow
(32). Further large-scale studies are necessary to
address the predictors of LV systolic stress improve-
ment. Nevertheless, in view of our data and those of
others (6), intense medical therapy is recommended
in hypertensive patients with calciﬁc degenerative
AS, regardless of whether they ﬁnally do or do not
undergo valve replacement.STUDY LIMITATIONS. The ﬂow acquisition system
measures aortic ﬂow velocity by using a very small
Doppler sample volume. Therefore, signals may
sometimes be noisy in highly turbulent ﬂows, as in
AS, and not account for the average ﬂow velocity for
the full cross-section of the aorta where measure-
ments are obtained. The geometry of the Corevalve
prosthesis can modify the local mechanical properties
of the arterial wall in the aortic root. For this reason,
we acquired the invasive pressure and ﬂow rate/
velocity signals 5 cm distal to the aortic annulus,
searching for the highest velocities at this point,
attempting to minimize the prosthesis’ local effects.
To avoid these issues, we selected data with the
highest quality available and implemented ﬁltering
and ensemble averaging to increase the signal-to-
noise ratio. However, we cannot exclude the fact
that residual high-frequency noise may account for
the relatively high Zc values that were measured.
Although a stable conscious sedation level was
achieved in all cases, a certain vascular tone
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Relief
of AS raises forward and backward compression
waves, increasing arterial pressure and both the
steady and pulsatile components of systemic arterial
load.
COMPETENCY IN PROCEDURAL SKILLS:
The increased post-procedural systemic vascular load
should be promptly treated when patients with AS
undergo TAVR, particularly when the transvalvular
pressure gradient is low.
TRANSLATIONAL OUTLOOK: Larger prospective
studies are needed to deﬁne the prognostic implica-
tions of changes in systemic vascular load that
immediately follow TAVR.
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432modiﬁcation can be expected for sedating drugs.
Similarly, some degree of vascular changes could be
caused by adaptation to acute procedure-related
myocardial injury.
We studied an elderly and high-risk AS group;
therefore, the vascular hemodynamics and response
to TAVR could be different in younger patients.
Functional improvement was only assessed using
NYHA functional classiﬁcation; other tools such as
the 6-min walk test or quality-of-life questionnaires
would have increased the sensitivity to detect func-
tional improvement. The small sample size was
designed to analyze the mechanistic changes in
vascular load. Thus, subgroup analyses need to be
interpreted cautiously, and hard clinical endpoints
could not be analyzed. With the small sample size, we
also could not address the impact of potential con-
founders such as degree of mitral regurgitation.
Large-scale clinical studies are necessary to rule out a
potential acute rebound effect post-intervention and
conﬁrm that post-TAVR measurements accurately
account for the true arterial load once the stenotic
damping effect has been alleviated.
CONCLUSIONS
Because valvular and vascular loads are tightly
coupled in AS, upstream obstruction can inﬂuence
the measurements of arterial properties. Low arterial
FCWs and BCWs caused by valvular stenosis produce
the hallmark signs of arterial hemodynamics in AS.
Relief of valvular obstruction with TAVR acutely in-
creases compression waves, causing the arterial tree
to operate at a higher pressure and therefore
increasing the vascular load. This phenomenonimpacts the post-procedural acute hemodynamic
beneﬁts of TAVR.
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